Inspire Medical Systems
(NYSE) INSP
Inspire Medical Systems Financials at a Glance
Market Cap
$1.44B
Revenue (TTM)
$911.98M
Net Income (TTM)
$145.42M
EPS (TTM)
$4.96
P/E Ratio
10.15
Dividend
$0.00
Beta (Volatility)
1.29 (Average)
Dividend
$0.00
Beta (Volatility)
1.29 (Average)
Price
$50.26
Volume
6
Open
$50.29
Price
$50.26
Volume
6
Open
$50.29
Previous Close
$50.41
Daily Range
$48.30 - $50.52
52-Week Range
$48.30 - $164.02
Dividend
$0.00
Beta (Volatility)
1.29 (Average)
Price
$50.26
Volume
6
Open
$50.29
Previous Close
$50.41
Daily Range
$48.30 - $50.52
52-Week Range
$48.30 - $164.02
INSP News
INSP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inspire Medical Systems
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,333
CEO
Timothy P. Herbert, MBA
Website
www.inspiresleep.comHeadquarters
Golden Valley, MN 55416, US
INSP Financials
Key Financial Metrics (TTM)
Gross Margin
85%
Operating Margin
6%
Net Income Margin
16%
Return on Equity
20%
Return on Capital
6%
Return on Assets
16%
Earnings Yield
9.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.44B
Shares Outstanding
28.59M
Volume
6
Short Interest
0.00%
Avg. Volume
1.25M
Financials (TTM)
Gross Profit
$778.76M
Operating Income
$50.95M
EBITDA
$64.91M
Operating Cash Flow
$116.98M
Capital Expenditure
$38.50M
Free Cash Flow
$78.48M
Cash & ST Invst.
$308.27M
Total Debt
$32.16M
Inspire Medical Systems Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$269.08M
+12.2%
Gross Profit
$233.01M
+14.4%
Gross Margin
86.59%
N/A
Market Cap
$1.44B
N/A
Market Cap/Employee
$1.16M
N/A
Employees
1,246
N/A
Net Income
$136.09M
+286.4%
EBITDA
$49.93M
-12.0%
Quarterly Fundamentals
Net Cash
$246.12M
-40.5%
Accounts Receivable
$119.69M
+28.6%
Inventory
$145.29M
+81.3%
Long Term Debt
$60.00M
+99.7%
Short Term Debt
$2.16M
+23.0%
Return on Assets
15.83%
N/A
Return on Invested Capital
6.20%
N/A
Free Cash Flow
$41.81M
-32.7%
Operating Cash Flow
$52.47M
-24.2%